Answers are grounded in this paper and cite their sources.
This cross-sectional study investigated characteristics and reporting of updates to artificial intelligence (AI)/machine learning–based medical devices cleared through the Food and Drug Administration (FDA) 501(k) pathway.
No takes yet. Share an insight, caveat, or question.
Zogka et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: